{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:52:11Z","timestamp":1791341531199,"version":"4.3.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004802","name":"California Breast Cancer Research Program","doi-asserted-by":"publisher","award":["W81XWH1810737"],"award-info":[{"award-number":["W81XWH1810737"]}],"id":[{"id":"10.13039\/100004802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218786","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:06:42Z","timestamp":1787587602000},"page":"218786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preclinical evaluation of trastuzumab deruxtecan in a new HER2+ leptomeningeal colonization model"],"prefix":"10.1016","volume":"660","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3890-326X","authenticated-orcid":false,"given":"Dinesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4491-3808","authenticated-orcid":false,"given":"Vanesa","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah F.","family":"Edmondson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-4634","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra S.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6103-2255","authenticated-orcid":false,"given":"Stanley","family":"Lipkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8234-1559","authenticated-orcid":false,"given":"Simone","family":"Difilippantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Steeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.canlet.2026.218786_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41568-024-00700-y","article-title":"The path to leptomeningeal metastasis","volume":"24","author":"Remsik","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218786_bib2","article-title":"Breaking barriers in leptomeningeal disease: a SNO-ASCO consensus review on clinical trial design and basic science integration","author":"Pina","year":"2026","journal-title":"Neuro Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218786_bib3","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/neuonc\/noae103","article-title":"Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions","volume":"26","author":"Wilcox","year":"2024","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218786_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101624","article-title":"Leptomeningeal metastasis from solid tumours: EANO-ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"8","author":"Le Rhun","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.canlet.2026.218786_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.critrevonc.2019.01.020","article-title":"Leptomeningeal carcinomatosis in patients with breast cancer","volume":"135","author":"Franzoi","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218786_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-019-05317-6","article-title":"Breast leptomeningeal disease: a review of current practices and updates on management","volume":"177","author":"Figura","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.canlet.2026.218786_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051192","article-title":"Neratinib and capecitabine for the treatment of leptomeningeal metastases from HER2-Positive breast cancer: a series in the setting of a compassionate program","volume":"14","author":"Pellerino","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.canlet.2026.218786_bib8","article-title":"Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in HER2+breast cancer: TBCRC049 phase 2 study results","volume":"42","author":"O'Brien","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.canlet.2026.218786_bib9","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1158\/1078-0432.CCR-18-3502","article-title":"Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer patients with central nervous system metastases","volume":"25","author":"Morikawa","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218786_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.breast.2023.04.008","article-title":"Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+\u00a0breast cancer leptomeningeal metastases","volume":"69","author":"Lazaratos","year":"2023","journal-title":"Breast"},{"issue":"7","key":"10.1016\/j.canlet.2026.218786_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1914510","article-title":"Trastuzumab deruxtecan in previously treated HER2-positive breast cancer","volume":"382","author":"Modi","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218786_bib12","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1038\/s41467-025-58266-8","article-title":"Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)","volume":"16","author":"Tsao","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2026.218786_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41523-023-00519-0","article-title":"Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan","volume":"9","author":"Alder","year":"2023","journal-title":"NPJ Breast Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2026.218786_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s12282-024-01614-1","article-title":"Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and\/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM)","volume":"31","author":"Nakayama","year":"2024","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218786_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-023-00584-5","article-title":"Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and\/or leptomeningeal disease (ROSET-BM)","volume":"9","author":"Niikura","year":"2023","journal-title":"NPJ Breast Cancer"},{"issue":"20","key":"10.1016\/j.canlet.2026.218786_bib16","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1158\/0008-5472.CAN-20-0291","article-title":"Brain metastasis cell lines panel: a public resource of organotropic cell lines","volume":"80","author":"Valiente","year":"2020","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2026.218786_bib17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cell.2017.02.025","article-title":"Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis","volume":"168","author":"Boire","year":"2017","journal-title":"Cell"},{"issue":"8073","key":"10.1016\/j.canlet.2026.218786_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-09012-z","article-title":"Interferon-\u03b3 orchestrates leptomeningeal anti-tumour response","volume":"643","author":"Remsik","year":"2025","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.canlet.2026.218786_bib19","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-20-3317","article-title":"Inhibition of Jumonji Histone demethylases selectively suppresses HER2+ breast leptomeningeal carcinomatosis growth via inhibition of GMCSF expression","volume":"81","author":"Bhan","year":"2021","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.canlet.2026.218786_bib20","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1158\/0008-5472.CAN-21-0259","article-title":"Autocrine GMCSF signaling contributes to growth of HER2(+) breast leptomeningeal carcinomatosis","volume":"81","author":"Ansari","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218786_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noag002","article-title":"Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier and distribution to tumor cells in HER2+ brain metastasis model systems","author":"Khan","year":"2026","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218786_bib22","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1535-7163.1585.3.12","article-title":"Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer","volume":"3","author":"Tanner","year":"2004","journal-title":"Mol. Cancer Therapeut."},{"issue":"21","key":"10.1016\/j.canlet.2026.218786_bib23","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1158\/1078-0432.CCR-15-1836","article-title":"Alterations in pericyte subpopulations are associated with elevated blood-tumor barrier permeability in experimental brain metastasis of breast cancer","volume":"22","author":"Lyle","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2026.218786_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/neuonc\/noae025","article-title":"Distinct uptake and elimination profiles for trastuzumab, human IgG, and biocytin-TMR in experimental HER2+brain metastases of breast cancer","volume":"26","author":"Silvestri","year":"2024","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218786_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/1535-7163.MCT-22-0815","article-title":"Comparison of three transcytotic pathways for distribution to brain metastases of breast cancer","volume":"22","author":"Khan","year":"2023","journal-title":"Mol. Cancer Therapeut."},{"issue":"12","key":"10.1016\/j.canlet.2026.218786_bib26","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jamaoncol.2016.0237","article-title":"Neratinib plus paclitaxel vs trastuzumab plus paclitaxel in previously untreated metastatic ERBB2-Positive breast cancer the NEfERT-T randomized clinical trial","volume":"2","author":"Awada","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218786_bib27","first-page":"289","article-title":"Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases","volume":"8","author":"Ricciardi","year":"2015","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.canlet.2026.218786_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-025-02088-5","article-title":"Trastuzumab deruxtecan in patients with active brain metastases from HER2-positive\/low metastatic breast cancer: a retrospective multicenter real-world study","volume":"27","author":"Duan","year":"2025","journal-title":"Breast Cancer Res."},{"issue":"12","key":"10.1016\/j.canlet.2026.218786_bib29","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1038\/s41591-024-03261-7","article-title":"Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b\/4 trial","volume":"30","author":"Harbeck","year":"2024","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218786_bib30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/1078-0432.CCR-22-1138","article-title":"Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases","volume":"29","author":"Kabraji","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218786_bib31","first-page":"noaa118","article-title":"A HER2 antibody drug conjugate controls growth of breast cancer brain metastasis in hematogenous xenograft models, with heterogeneous blood-tumor barrier penetration unlinked to a passive marker","author":"Gril","year":"2020","journal-title":"Neuro Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218786_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112795","article-title":"Molecular assessment of HER2 to identify signatures associated with therapy response in HER2-positive breast cancer","volume":"14","author":"Maddox","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.canlet.2026.218786_bib33","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1101\/pdb.top073585","article-title":"Human cancer growth and therapy in immunodeficient mouse models","volume":"2014","author":"Shultz","year":"2014","journal-title":"Cold Spring Harb. Protoc."},{"issue":"1","key":"10.1016\/j.canlet.2026.218786_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13058-021-01487-8","article-title":"Periostin gene expression in neu-positive breast cancer cells is regulated by a FGFR signaling cross talk with TGFbeta\/PI3K\/AKT pathways","volume":"23","author":"Labreche","year":"2021","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2026.218786_bib35","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5670","article-title":"Periostin: a matricellular protein with a multifaceted role in tumorigenesis","volume":"56","author":"Xian","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"10.1016\/j.canlet.2026.218786_bib36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nm.2379","article-title":"Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs","volume":"17","author":"Oskarsson","year":"2011","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.canlet.2026.218786_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-023-04428-x","article-title":"Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis","volume":"164","author":"Hou","year":"2023","journal-title":"J. Neuro Oncol."},{"issue":"21","key":"10.1016\/j.canlet.2026.218786_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213683","article-title":"Integrin alpha6beta4 upregulates PTPRZ1 through UCHL1-Mediated Hif-1alpha nuclear accumulation to promote triple-negative breast cancer cell invasive properties","volume":"16","author":"Chen","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"10C","key":"10.1016\/j.canlet.2026.218786_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4236\/abb.2013.410A4003","article-title":"Role of TGF-beta in breast cancer bone metastases","volume":"4","author":"Chiechi","year":"2013","journal-title":"Adv. Biosci. Biotechnol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218786_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","article-title":"TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4","volume":"133","author":"Padua","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218786_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214430","article-title":"COL4A2 drives ECM remodeling and stiffness increasing to promote breast cancer metastasis via YAP signaling pathway in dECM induced models","volume":"177","author":"Peng","year":"2025","journal-title":"Biomater. Adv."},{"issue":"1","key":"10.1016\/j.canlet.2026.218786_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13058-025-02088-5","article-title":"Trastuzumab deruxtecan in patients with active brain metastases from HER2-positive\/low metastatic breast cancer: a retrospective multicenter real-world study","volume":"27","author":"Duan","year":"2025","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2026.218786_bib43","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ccr.2011.08.025","article-title":"Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs","volume":"20","author":"Chen","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218786_bib44","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1038\/s41467-021-25189-z","article-title":"ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer","volume":"12","author":"Taftaf","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.canlet.2026.218786_bib45","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cell.2017.02.025","article-title":"Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis","volume":"168","author":"Boire","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.canlet.2026.218786_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0404.1995.tb00420.x","article-title":"Immunocytochemical detection of tumor necrosis factor-alpha in infiltrating tumor cells in the cerebrospinal fluid from five patients with leptomeningeal carcinomatosis","volume":"91","author":"Nakamura","year":"1995","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.canlet.2026.218786_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-019-05317-6","article-title":"Breast leptomeningeal disease: a review of current practices and updates on management","volume":"177","author":"Figura","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"issue":"35","key":"10.1016\/j.canlet.2026.218786_bib48","doi-asserted-by":"crossref","first-page":"58338","DOI":"10.18632\/oncotarget.16873","article-title":"Inflammatory factor TNF-alpha promotes the growth of breast cancer via the positive feedback loop of TNFR1\/NF-kappaB (and\/or p38)\/p-STAT3\/HBXIP\/TNFR1","volume":"8","author":"Cai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218786_bib49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2018.00024","article-title":"Multifaceted role of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR): Diagnostic, prognostic, and therapeutic applications","volume":"8","author":"Mahmood","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218786_bib50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.omto.2020.12.014","article-title":"Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target?","volume":"20","author":"Liu","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"1","key":"10.1016\/j.canlet.2026.218786_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-024-02121-7","article-title":"AXL signaling in cancer: from molecular insights to targeted therapies","volume":"10","author":"Yadav","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.canlet.2026.218786_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-025-01412-y","article-title":"Leptomeningeal disease: current approaches and future directions","volume":"25","author":"Sener","year":"2025","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"12","key":"10.1016\/j.canlet.2026.218786_bib53","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1158\/2159-8290.CD-22-0837","article-title":"Trastuzumab deruxtecan in HER2-Positive metastatic breast cancer patients with brain metastases: a DESTINY-Breast01 subgroup analysis","volume":"12","author":"Jerusalem","year":"2022","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.canlet.2026.218786_bib54","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41571-021-00529-6","article-title":"The blood-tumour barrier in cancer biology and therapy","volume":"18","author":"Steeg","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218786_bib55","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20212121","article-title":"The anatomic basis of leptomeningeal metastasis","volume":"221","author":"Freret","year":"2024","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.canlet.2026.218786_bib56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.anorl.2011.03.002","article-title":"Anatomy and physiology of cerebrospinal fluid","volume":"128","author":"Sakka","year":"2011","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:22:27Z","timestamp":1791339747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526005501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S0304383526005501"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218786","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of trastuzumab deruxtecan in a new HER2+ leptomeningeal colonization model","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218786"}}